Telix Pharmaceuticals Limited (ASX:TLX)

Telix Pharmaceuticals Revenue

In the year 2025, Telix Pharmaceuticals had annual revenue of $803.79M USD with 55.61% growth. Telix Pharmaceuticals had revenue of $413.44M in the half year ending December 31, 2025, with 122.47% growth.

• Revenue: $803.79M
• Revenue Growth: +55.61%
• P/S Ratio: 4.00
• Revenue / Employee: $678.88K
• Employees: 1,184
• Market Cap: 4.82B AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	803.79M	287.24M	55.61%
Dec 31, 2024	516.55M	183.57M	55.13%
Dec 31, 2023	332.98M	224.03M	205.64%
Dec 31, 2022	108.95M	103.42M	1,873.25%
Dec 31, 2021	5.52M	1.51M	37.53%
Dec 31, 2020	4.01M	1.57M	64.21%
Dec 31, 2019	2.44M	2.31M	1,680.89%
Dec 31, 2018	137.28K	-	-
Dec 31, 2017	-	-	-

Data Source: Fiscal.ai Last updated: Dec 31, 2025

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 22, 2026

Data Sources Report a data error